Navigation Links
Inovio Pharmaceuticals, Transgene and ChronTech Pharma to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
Date:4/18/2011

BLUE BELL, Pa., April 18, 2011 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO), a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today it has signed a collaboration agreement with Transgene S.A. (Euronext Paris: FR0005175080) and ChronTech Pharma AB (CTEC.ST) to evaluate a novel therapeutic vaccination strategy against genotype 1 hepatitis C virus (HCV) in a phase I clinical study.

It is common to follow an initial "prime" vaccination with a "boost" of the same vaccine to achieve the required level and durability of immune protection. In this collaboration, the strategy is to use different prime and boost vaccines with the goal of obtaining a clinical effect by inducing different immune responses. A Phase I study, to be started later this year, will use ChronTech's ChronVac-C® plasmid DNA vaccine delivered by in vivo electroporation using Inovio's Medpulser® DDS as the "prime" and Transgene's therapeutic vaccine TG4040, a modified vaccinia Ankara (MVA), as the "boost".

DNA based vaccines delivered using electroporation and MVA based vaccines have been separately shown to be safe and immunogenic in clinical studies. The ChronVac-C DNA vaccine delivered by in vivo electroporation using the Medpulser was recently reported to be safe and generate antigen specific immune responses and antiviral effects in a phase I/IIa clinical trial. Rapid virologic responses were seen in 5 out of 7 of the patients receiving a post-vaccination standard of care interferon-ribavirin therapy. TG4040 was itself shown to be safe and immunogenic in a phase I program. Phase II studies in combination with the standard of care are ongoing for both products. In preclinical studies, the novel combination of these DNA and MVA vaccine approaches demonstrated greater immune responses than those obs
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
2. University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
3. Inovio Pharmaceuticals Dual-Antigen SynCon™ DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
4. Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
5. Inovio Pharmaceuticals to Present at Partnering and Scientific Conferences
6. Inovio Pharmaceuticals to Present at Cowen & Co. Health Care Conference
7. Inovio Pharmaceuticals to Present at ROTH 23rd Annual Growth Stock Conference
8. Inovio Pharmaceuticals Partner ChronTech Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovios Electroporation Delivery Technology
9. OncoSec Medical Licenses Non-DNA Vaccine Tumor Therapy Technology from Inovio Pharmaceuticals
10. Inovio Pharmaceuticals Licenses Non-DNA Vaccine Tumor Therapy Technology to OncoSec Medical
11. Inovio Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , August 27, 2015 According ... Market by Type (Integrated, Standalone), by Deployment Mode (Web ... Physicians, Emergency Healthcare Service Providers), by Component - Global ... Systems Market is estimated at $501.1 Million 2014, and ... a CAGR of 7.6% from 2014 to 2019. ...
(Date:8/27/2015)... 2015  BioElectronics Corporation (OTC Pink: BIEL), the maker ... abstracts featuring the use of ActiPatch®, its novel musculoskeletal ... Congress of the European Pain Federation EFIC®, ... 2015. The Company will also be exhibiting at the ... Bagnato , department clinical and experimental rheumatology from the ...
(Date:8/27/2015)... --  Americord Registry , a private cord blood ... banking company, announced today the launch of their ... website makes the expecting parent,s cord blood banking purchase ... checkout process. Logo - http://photos.prnewswire.com/prnh/20150827/261520LOGO ... this service difficult to purchase online. We want to ...
Breaking Medicine Technology:Radiology Information Systems Market Worth $722.7 Million by 2019 2Radiology Information Systems Market Worth $722.7 Million by 2019 3Radiology Information Systems Market Worth $722.7 Million by 2019 4BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2Cord Blood Bank Revolutionizes Process of Online Cord Blood Banking 2
... Va., Nov. 16 As a two-time cancer survivor, Bill Still ... Sentara Cancer Network first-hand. When Bill,s prostate cancer ... group with the help of a community outreach nurse at Sentara ... care delivery system, he was largely on his own. , Bill ...
... , MAPLE GROVE, Minn., Nov. 16 ... Treatment of L ipoproteins and I nflammatory ... Journal of Clinical Lipidology . The objective was to ... and Lipitor (atorvastatin calcium) 10 mg/day, given alone and then ...
Cached Medicine Technology:Sentara Cancer Network Earns National Accreditation 2New Data: Cholesterol Management Analysis of Upsher-Smith's Slo-Niacin(R) Tablets in Combination with Lipitor(R) 2New Data: Cholesterol Management Analysis of Upsher-Smith's Slo-Niacin(R) Tablets in Combination with Lipitor(R) 3New Data: Cholesterol Management Analysis of Upsher-Smith's Slo-Niacin(R) Tablets in Combination with Lipitor(R) 4
(Date:8/27/2015)... ... August 27, 2015 , ... Allegheny General Hospital ... 20 adult-only medical centers in the United States to receive international recognition for ... The Extracorporeal Life Support Organization (ELSO) , an international consortium of healthcare ...
(Date:8/27/2015)... ... August 27, 2015 , ... About 10 percent ... into the Gulf Coast, killing more than 1,800 people, displacing hundreds of thousands ... Georgia State University study. , While most people don’t develop persistent depression after ...
(Date:8/27/2015)... CA (PRWEB) , ... August 27, 2015 , ... ... & IoT Summit , scheduled for October 27-29, 2015 in San Jose, CA. ... the summit will primarily focus on the void that exists where battery development ...
(Date:8/27/2015)... ... August 27, 2015 , ... Zensah®, the premium ... Tennis player for Israel in the Women’s Tennis Association (WTA). Glushko competes in ... and recovery. , With a focus on technology and comfort, Zensah® has developed ...
(Date:8/27/2015)... CITY, Tenn. (PRWEB) , ... August 27, 2015 , ... ... LLC, DBA All Clear System. The agreement will enable both Johnson City, Tenn.-based firms ... All Clear System is a cloud-based safety product that caters to organizations in the ...
Breaking Medicine News(10 mins):Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 2Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 3Health News:International Organization Honors Allegheny General Hospital's Advanced Lifesaving Program for Cardiac and Respiratory Failure 4Health News:About 10 Percent of Mothers Experienced Depression Two Years After Hurricane Katrina, New Study Shows 2Health News:Infocast Hosting First Conference Dedicated to Powering Wearable Devices & the IoT 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 2Health News:Zensah® Compression Announces Partnership with WTA Tennis Professional Athlete, Julia Glushko 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4
... Ind., Feb. 27 Zimmer Holdings, Inc. (NYSE: ... N. Casper, Executive Vice President and Chief Operating Officer ... its Board of Directors. Thermo Fisher Scientific, the ... equipment, supplies and services used in life sciences, healthcare, ...
... System, as Inventor of the Month for February 2009SAN ... ADSK ) has named Cochlear Bone Anchored Solutions, a ... in the development and manufacturing of implantable hearing solutions, ... February 2009.Cochlear successfully used Autodesk Inventor software ...
... by Communion and Liberation: D A T E: Friday, February 27, 2009 ... Gowan Hall ( Nursing-Biology Building ), ... 620 Michigan Avenue NE , Washington , ... Different Way of Facing H.I.V. -- From Sickness and Despair to a New Life: ...
... a Highly Effective and Affordable New Option to Help ... Derma Sciences, Inc. (OTC Bulletin ... announced today that its first BIOGUARD Barrier Dressings have ... for marketing and distribution. BIOGUARD will offer surgeons, ...
... Novalar Pharmaceuticals, Inc., a dental specialty pharmaceutical ... company,s premier dental pharmaceutical product. OraVerse is the ... accelerates the return to normal sensation and function ... and unnecessary lingering soft tissue anesthesia following routine ...
... University of Pittsburgh Medical Center (UPMC) and Paphos Plantations Ltd. (PPL) - ... collaborating to develop a world-class health care center in Paphos, Cyprus, designed ... and foreign visitors to this Mediterranean island. , ... Pittsburgh, PA and ...
Cached Medicine News:Health News:Zimmer Holdings Names Marc Casper to Board of Directors 2Health News:Zimmer Holdings Names Marc Casper to Board of Directors 3Health News:Superior Sound Amplifies Quality of Life for the Deaf and Hard of Hearing 2Health News:Superior Sound Amplifies Quality of Life for the Deaf and Hard of Hearing 3Health News:Superior Sound Amplifies Quality of Life for the Deaf and Hard of Hearing 4Health News:Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology 2Health News:Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology 3Health News:Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology 4Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 2Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 3Health News:Video: Novalar Announces the Launch of OraVerse(TM) the First Dental Anesthesia Reversal Agent 4Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 2Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 3Health News:University of Pittsburgh Medical Center to Manage New Health Center in Cyprus 4
The Snap-In Snap-Out-II Tip Inserts offer a large variety of configurations....
The ACMI™ line of laparoscopic hand instruments is designed to provide a wide selection of popular surgical devices to meet procedural needs....
This probe coagulates bleeders while suction channel with trumpet valve simultaneously evacuates smoke....
Bair Hugger temperature management units are the only forced-air warming systems that can be used with an integrated, cost-effective method of fluid warming...
Medicine Products: